Exit Text Mode

Macular Disease Foundation Australia logo

    MDFA News

    Saving sight will save billions of dollars

    An investment to save the sight of thousands of vulnerable older Australians will save the Government up two billion dollars.

    Read more

    Most recent

    Vision Voice: Read our latest newsletter

    Welcome to the special My Eyes edition of Vision Voice.

    MDFA’s first South Australian Peer Support group to launch in April

    Connecting with other people who are going through similar health experiences can improve how you manage your own condition.

    Social Impact Survey 2: What did your patients tell us?

    Macular Disease Foundation Australia (MDFA) is committed to understanding the impact of macular disease on the lives and health of people who live with the condition. One of the ways we do this is through our Social Impact research.

    Diabetic eye disease: Laying the foundations for new treatments

    Professor Chandra Balaratnasingam’s MDFA-funded research is exploring the cellular changes that occur in diabetic macular ischaemia (DMI) to help develop a breakthrough therapy.

    Improving the diagnosis of macular disease

    Grant Family Fund support is allowing Dr Alexis Ceecee Britten-Jones to research a way to ensure people with rare inherited macular dystrophies receive the right treatment for them in future.

    AI, NASA and dry AMD

    Find out how the Grant Family Fund is helping Dr Xavier Hadoux use cutting-edge technology to detect the early signs of macular disease.

     Could a new supplement help slow AMD?

    A/Prof Gerald Liew’s second MDFA Research Grant is allowing him to investigate a potential sight-saving supplement to improve dysfunctional mitochondria and prevent age-related macular degeneration (AMD). 

    Read our latest Vision Voice newsletter today 

    Our final Vision Voice for the year celebrates two remarkable centenarian members of our community who are vigilant in maintaining their vision with sight-saving eye injections.

    MDFA partners with TerryWhite Chemmart for national campaign

    MDFA and TerryWhite Chemmart are providing people aged 50+ with a fast, easy way to understand and assess their general risk factors for macular disease.